We are live on ! Find out more
EWM

Endurance Wealth Management Portfolio holdings

AUM $731M
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.02%
5 Year Est. Return
+95.35%
10 Year Est. Return
+224.8%
AUM
$533M
AUM Growth
-$180M
Cap. Flow
+$6.97M
Cap. Flow %
1.31%
Top 10 Hldgs %
29.41%
Holding
526
New
12
Increased
66
Reduced
127
Closed
23

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$3.37M
2
AGN
Allergan plc
AGN
+$3.36M
3
QCOM icon
Qualcomm
QCOM
+$2.52M
4
DVYE icon
iShares Emerging Markets Dividend ETF
DVYE
+$1.52M
5
AKAM icon
Akamai
AKAM
+$822K

Sector Composition

Rank Sector Weight
1 Miscellaneous 16.57%
2 Healthcare 15.88%
3 Energy 15.22%
4 Technology 14.2%
5 Financials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDB icon
26
Independent Bank
INDB
$3.89B
$7.12M 1.34%
155,889
PFE icon
27
Pfizer
PFE
$159B
$7M 1.32%
209,654
+4,929
+2% +$157K
PEP icon
28
PepsiCo
PEP
$193B
$6.83M 1.28%
64,438
+1,200
+2% +$124K
ABBV icon
29
AbbVie
ABBV
$451B
$6.78M 1.27%
109,526
-3,550
-3% -$216K
SLB icon
30
SLB Ltd
SLB
$85.1B
$6.64M 1.25%
83,973
+30
+0% +$2.3K
AGN
31
DELISTED
Allergan plc
AGN
$6.57M 1.23%
28,441
+14,552
+105% +$3.36M
MDLZ icon
32
Mondelez International
MDLZ
$79.6B
$6.24M 1.17%
137,062
+1,550
+1% +$67.5K
DM
33
DELISTED
Dominion Energy Midstream Ptr LP
DM
$6.17M 1.16%
219,281
+3,800
+2% +$113K
CHD icon
34
Church & Dwight Co
CHD
$24B
$5.98M 1.12%
116,184
-1,490
-1% -$71.9K
WFC icon
35
Wells Fargo
WFC
$262B
$5.47M 1.03%
115,655
-320
-0.3% -$15.6K
VHT icon
36
Vanguard Health Care ETF
VHT
$19.3B
$5.38M 1.01%
41,200
JNJ icon
37
Johnson & Johnson
JNJ
$646B
$5.23M 0.98%
43,085
-806
-2% -$91.6K
MUB icon
38
iShares National Muni Bond ETF
MUB
$45.5B
$5M 0.94%
43,905
-241
-0.5% -$27.1K
NEE icon
39
NextEra Energy
NEE
$171B
$4.66M 0.87%
142,928
-5,388
-4% -$162K
CSCO icon
40
Cisco
CSCO
$433B
$4.57M 0.86%
159,339
+120,226
+307% +$3.37M
WY icon
41
Weyerhaeuser
WY
$17B
$4.42M 0.83%
148,635
HAS icon
42
Hasbro
HAS
$13.3B
$4.37M 0.82%
52,003
-625
-1% -$52.9K
NXPI icon
43
NXP Semiconductors
NXPI
$56.4B
$3.96M 0.74%
50,497
+970
+2% +$83.2K
TEVA icon
44
Teva Pharmaceuticals
TEVA
$42.5B
$3.76M 0.71%
74,928
+5,200
+7% +$277K
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$4.24T
$3.67M 0.69%
104,320
-400
-0.4% -$14.7K
AIG icon
46
American International
AIG
$40.2B
$3.63M 0.68%
68,704
-3,727
-5% -$206K
PG icon
47
Procter & Gamble
PG
$334B
$3.36M 0.63%
39,643
+502
+1% +$41.2K
CL icon
48
Colgate-Palmolive
CL
$72.3B
$3.34M 0.63%
45,693
-508
-1% -$36.2K
GILD icon
49
Gilead Sciences
GILD
$181B
$3.23M 0.61%
38,739
-650
-2% -$57.7K
EQM
50
DELISTED
EQM Midstream Partners, LP
EQM
$3.1M 0.58%
38,639
-500
-1% -$37.7K

Similar funds

Endurance Wealth Management's Q2 2016 Portfolio in Review

As of Q2 2016, Endurance Wealth Management held 526 positions worth $533M, down 25% from $712M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Endurance Wealth Management's Q2 2016 filing shows 12 new, 66 increased, 127 reduced and 23 closed positions. Its largest new stake was Happen Inc: 2,500 shares worth $54K. The largest sale was GE Aerospace, an estimated $1.08M.

By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Energy.

  • Endurance Wealth Management's largest Q2 2016 buy was Happen Inc: 2,500 shares worth $54K.
  • Endurance Wealth Management added most to Cisco in Q2 2016, an estimated $3.37M increase.
  • Endurance Wealth Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $1.08M.
  • Endurance Wealth Management fully exited BioMarin Pharmaceuticals in Q2 2016, selling an estimated $82K.
  • Endurance Wealth Management's ten largest holdings make up 29% of its $533M portfolio in Q2 2016.
  • Endurance Wealth Management opened 12 new positions and closed 23 in Q2 2016.
  • Endurance Wealth Management's portfolio value fell 25% quarter-over-quarter to $533M.

Based on Endurance Wealth Management's 13F filing for Q2 2016, filed 4 Aug 2016.